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Pervasive transcriptionThe dogmatic view of RNA as a mere necessity in the transfer of information between DNA and proteins has
during recent years come into question. Novel approaches and new technology has revealed an
unprecedented level of inherent complexity in the mammalian transcriptome. Here, the majority of
nucleotides are expressed, in sharp contrast to the ∼1.2% of the human genome harboring protein coding
information. Also, N50% of genomic loci contain antisense and interleaved transcription, a conservative
estimate since non-coding RNA is highly regulated between tissues and developmental stages, which has
only been investigated to a limited extent. Subsequent focus on RNA with no coding potential has revealed
numerous species with novel functions, and deep sequencing studies imply that many remain to be
discovered. This review gives an overview of the plasticity and dynamics of the mammalian transcriptome
and the prevailing interpretation of its effect on the complexity of species.
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Our view of genomes, corresponding transcriptomes and the ﬂow
of genetic information as described by the central dogma, have long
been characterized by simple prokaryotic models. Here, the informa-
tion is passed from DNA via messenger RNA (mRNA) to proteins, a
process controlled by ﬂanking regulatory 5′/3′ sequences working in
concert with regulatory proteins. In addition, the genetic output is
considered to be almost exclusively transacted by proteins, which
lead to the oversimpliﬁed meaning of the term “gene” as a section of
the DNA whose corresponding RNA encodes a protein. In the light of
these assumptions the mammalian transcriptome was considered to
consist mainly of ribosomal RNA (∼80%, rRNA), transfer RNA (∼15%,
tRNA), mRNA (2–4%) and a small proportion of non-coding RNA (∼1%,
ncRNA) with regulatory functions. This model was extrapolated to
higher multicellular organisms, despite conﬂicting reports on the
composition of polyadenylated (poly A+) and non-polyadenylated
(poly A−) RNA more than 30 years ago [1–3]. Moreover, the@biotech.kth.se (J. Lundeberg).
ll rights reserved.indisputable correlation between proportions of non-coding DNA
(ncDNA) and complexity (% ncDNA: prokaryotes b0.25%; simple
eukaryotes 25–50%; more complex fungi and animals N50%; humans
∼98.8%) [4] suggested that the common opinion of ncDNA as junk or
evolutionary debris was fundamentally ﬂawed.
It was not until 2002, when tiling arrays were introduced, allowing
high-resolution, high-throughput scanning over large genomic
regions that the extent of mammalian transcription was starting to
be recognized [5]. Later, the same year, a collection of ∼61,000
sequenced full-length cDNA clones of mRNA in mice combined with
public sequence resources were analyzed and published by the
FANTOM consortium [6]. Surprisingly, ∼47% of ∼30,000 identiﬁed
transcriptionally active loci did not harbor protein coding potential
and were identiﬁed to represent novel, potentially functional ncRNAs.
These ﬁndings were veriﬁed by Bertone et al. [7], where triple selected
poly A+ RNA from a pool of liver tissues was investigated with tiling
arrays. Except for 64% (∼11,000) of presently annotated RefSeq [8]
genes, ∼10,500 distinct regions located outside annotated exons were
found to be transcriptionally active. In two subsequent studies by the
FANTOM consortium, various cloning approaches were applied to
retrieve, e.g., ∼180,000 transcripts with paired initiation and
termination boundaries in combination with public resources to
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analysis revealed a multifaceted, widespread, overlapping transcrip-
tional landscape, which called for new deﬁnitions. When clustering
transcriptional frameworks (overlapping transcripts sharing a splic-
ing event, start or termination site) into transcriptional forests (non-
interrupted transcriptionally active regions on either strand) it
comprised ∼63% of the genome with interspersed transcriptional
deserts. ∼65% of transcriptional units (overlapping mRNA which
share direction and strand) were alternatively spliced which
commonly affected domain content or organization and ∼72%
contained antisense transcription. Analysis of CAGE (cap analysis of
gene expression, allows for 5′ end identiﬁcation of transcripts) tags
[11] revealed an overrepresentation of annotated transcripts initiating
not only from the 5′ end, but also from the 3′ end. In addition, ∼1/3 of
all full-length cDNA did not appear to harbor any protein coding
sequence, and many were only detected once, indicating low levels of
expression. Although ncRNA were on average less conserved than 5/
3′ UTRs (untranslated regions) or coding sequences, the relationship
was surprisingly opposite for promoter regions, which may suggest
functionality.
Another level of inherent complexity was added to prevailing
model by Cheng and colleagues [12]. Here, tiling arrays, sequencing of
reversely transcribed transcripts and real-time PCR was used to
investigate poly A±RNA from the cytosol and nucleus separately. In
total, ∼44% of expressed nucleotides were poly A−, ∼19% poly A+
and ∼37% bimorphic (either poly A+ or poly A−). These patterns
were further investigated by sequencing, since bimorphic transcripts
could potentially arise from either strands, and the results showed
that ∼50% of investigated loci harbored antisense transcription. The
nucleus was found to contain ca. ﬁve times the number of expressed
nucleotides than the cytosol and of all transcripts, ∼50% were unique
for the nucleus, ∼10% for the cytosol and ∼40% were present in both.
Subsequently in June 2007 the ENCODE pilot project was published
[13].
ENCODE is a public research consortiumwith the aim to identify all
functional elements in the human genome. The pilot project covered
1% of the human genome and although ∼15% of interrogate
nucleotides were found to be transcribed in one tissue sample ∼93%
of all bases were represented in a primary transcript according to at
least two independent observations. ∼40% of all identiﬁed transcripts
were present in only one sample, and only ∼2% were present in all
samples. These ﬁndings conﬁrm the extent of differential transcrip-
tion in different tissues [12,14] and indicate a regulatory role.
Ampliﬁcation of 5′ ends was used, in combination with tiling arrays,
to investigate the diversity of transcripts emanating from protein-
coding loci. 90% of interrogated loci encoded transcripts with novel
exons 50–100 kb upstream of the annotated TSSs (transcription start
sites) and ∼50% contained at least one exon from an upstream gene.
On average, 5.4 transcripts were detected per locus. ∼19% of
pseudogenes were found to be transcriptionally active which concurs
with previous work by the FANTOM consortium, where a high
proportion (∼10%) of all detected transcripts mapped to pseudogenes
[15]. The correlation between queried protein factors associated with
histones and DNaseI hypersensitive sites veriﬁed the pattern of
unprecedented transcription. The proportions of novel TSSs associat-
ed with clusters of histone modiﬁcations and DNaseI hypersensitive
sites were larger than for previously known and identiﬁed TSSs. Note,
the known and novel TSSs contained the same histone modiﬁcations,
indicating that they were regulated by the same processes. Observa-
tions in other species, such as yeast, worm and fruit ﬂy conﬁrm the
pervasive (70–85%) transcriptional patterns [16–18]. Taken together,
the studies from the FANTOM consortium, ENCODE and others have
caused the gene deﬁnition to come under scrutiny as discussed by
Gerstein and colleagues [19]. Here, focus was set on function and an
updated deﬁnition is suggested to be “a union of genomic sequences
encoding a coherent set of potentially overlapping functionallyproducts.” This basically projects the functional products down to
overlapping sequences and excludes regulatory sequences. Since
regulatory sequences have a many-to-many relationship these are too
complex to be included in the deﬁnition and are instead suggested to
be deﬁned in a class of “gene-associated sequences.”
During 2008, new technology [20] has increased the throughput of
sequencing to the extent where it is becoming feasible to sequence
transcriptomes instead of using hybridization-based approaches [21].
Targeting the polyadenylated component of the transcriptome, ∼35%
mapped to intergenic regions [22,23]. Also, by sequencing RNA from
transcriptionally active polymerases of primary human lung ﬁbro-
blasts, 68% of RefSeq [8] genes were found to be active and in 59%
antisense transcription was detected [24]. All-in-all, initial results
using next-generation-sequencing technology support and bring
novel knowledge on the current model of widespread interleaved,
complex transcription in mammalian genomes. E.g., recently, Faul-
kner et al. [25] investigated the retrotransposon transcriptome, with
focus on repetitive elements in the human genome. ∼31% of detected
TSS mapped to repetitive elements whose expression varied substan-
tially between tissues. The majority retrotransposon transcripts
initiated in novel promoters with a sharp dominant peak, bearing
similarity to TATA-box controlled genes, which to a great extent are
regulated between tissues and developmental stages [14]. Interest-
ingly, a subset of detected retrotransposon were found to provide
alternative promoters for Refseq genes [8].
Also, deep sequencing has allowed for unprecedented mapping of
splice variants, which drastically increase the estimates of the
proportion of alternatively spliced genes. 40–60% of all human
genes [26] and N70% of all multi-exon genes have previously been
suggested to be alternatively spliced [27] but Wang and colleagues
demonstrated that ∼93% of multi-exon genes are subject to
alternative splicing and 52–80% of all alternative-splicing events are
regulated between tissues depending on the type of splicing event
[28]. In addition, genome-wide interrogation of RNA editing [29,30],
an event leading to the conversion of, e.g., RNA adenosine to inosine,
which is interpreted by the ribosome as guanosine, is now beingmade
possible with next generation sequencing technology. In a recent
study, Li and colleagues [31] used padlock probes [32] to sequence
putative editing sites in DNA and RNA from several different tissues.
This revealed hundreds of edited sites, many with an editing level as
low as N2%, which is in stark contrast to the previously 13 known
edited sites.
What is the role of all this non-coding RNA?
What is all this RNA used for? ncRNAs have been suggested to
function as a digital information system with properties that allow
organisms to surmount complexity limits imposed by using only
regulatory proteins in conjunction with cis-regulatory elements. The
key problems associated with complex protein networks lie in
evolving systems capable of controlling them with the smallest
possible amount of resources. The increasing sophistication of control
architecture required as complexity increases is demonstrated by the
connection between the numbers of regulatory proteins and genome
sizes in prokaryotes, which scales quadratically. To overcome such
limitations a parallel, overlying control system is needed, which could
be provided by ncRNAs [33]. Furthermore, observations that organ-
isms such as Caenorhabditis elegans and Strongylocentrotus purpuratus
(sea urchin) host almost the same numbers of protein-coding genes
(∼19,000 and 23,000, respectively) as humans (∼20,500), suggesting
that the regulatory systems for higher complex organisms must lie
beyond protein networks. Alternative splicing has been proposed to
explain the surprisingly low number of genes in the human genome
[34,35], since Saccharomyces cerevisiae (for instance) has virtually no
introns [36]. However, in a comparison of seven species, the
proportion of alternatively spliced genes was not found to be higher
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questioned [38].
The complexity of mammalian transcriptomes is provocative and
has catalyzed a discussion whether the pervasive transcription in
mammalian transcriptomes is mainly noise [39] noise or not.
Importantly, several studies have shown that long ncRNA (lRNA)
does play a regulatory role by establishing that the pervasive ncRNA
expression is differentially expressed between tissues, cell types and
developmental stages [9,12–14,40–42]. In addition, lRNAs are subject
to alternative splicing [43], localize to subcellular compartments [44],
serve as structural components [45,46] and are strongly overrepre-
sented in differentially methylated regions between tissues, which
also argue for a role in regulation [47]. In a study worth attention,
Guttman et al. used chromatin-state maps in four mouse cell types
which identiﬁed ∼1600 putatively functional lRNAs where ∼95%
displayed evolutionary conservation [48]. These lRNA appeared to be
multi-exonic and to contain both poly A tail and 5′ cap. Subsequent
analysis revealed these lRNA to be involved in various processes, e.g.,
cell proliferation, immune surveillance, morphogenesis, ESC pluripo-
tency and muscle development, which was experimentally veriﬁed
for a subset. The developmental role is in line with work by Efroni and
coworkers [49] demonstrating that embryonic stem cells are
transcriptionally hyperactive on a global scale, which is reduced
after differentiation. Furthermore, the diversity of a species of small
RNA (sRNA), microRNA (miRNA), has been shown to correlate to
phenotypic complexity [50] and recent work, as exempliﬁed in S.
cerevisiae, demonstrates that chromatin-remodeling complexes ac-
tively regulate the chromatin state via mechanisms that minimize
inappropriate transcription [51].
In contrast, the estimation that only ∼5% of the human genome
is under purifying selection conﬂicts with the idea of a functional
regulatory system mediated by ncRNA [13,52]. These numbers
might seem paradoxical since sequences under no selective pressure
should theoretically acquire functions or be lost. In accordance with
this assumption is growing evidence that ancient and modern
repeats act as factories for gene promoters, genes, regulatory
elements, microRNA, etc., and newly detected classes of repeats
with variable sequence conservation, some of which are among the
slowest evolving entities in the human genome [53–59]. It is
important to note that ncRNA regulatory signals are not bound by
the same structure–function and multi-tasking relationships as
proteins, and can therefore exhibit faster evolutionary rates, which
has previously been discussed in great detail [60]. Collectively, these
ﬁndings and the growing ﬂood of functional ncRNAs [61–63] show
that the enormous ﬂows of information required during the
development of complex organisms such as mammals are likely to
be mediated by RNA, that proteins in conjunction with RNA execute
the program and proteins alone mediate the interaction with the
environment [62].
Regulatory RNA
The mammalian transcriptome consists of many types of non-
coding regulatory RNA. Examples are small nuclear RNA (snRNA),
transcripts ∼200 nucleotides long, that guide the spliceosome
complex and small nucleolar RNAs (snoRNAs), 60–300 nucleotides
long RNA molecules, directing associated proteins to execute
sequence-speciﬁc modiﬁcations (methylation, pseudouridylation)
on tRNA, rRNA or snRNA molecules in the nucleolus. Interestingly,
alternative functions have been suggested for snoRNA, e.g., regula-
tion of alternative splicing by binding to silencer elements, [64] or as
precursors for miRNA [65]. sRNAs are the most recent additions to
the RNA family, Only b30 nucleotides long, which hindered an earlier
discovery. piRNA (piwi-interacting RNA), discovered in Drosophila
[66], are 24–30 nt poorly conserved sRNA interacting with Piwi
proteins [67]. These have been associated with control of transpos-able elements and normal spermatogenesis in mammals [68,69].
Exogeneous siRNA (small interfering RNA) have been widely used
for gene silencing in laboratory settings by using the miRNA
associated Risc complex but so far the only endogenous class of
gene regulating sRNA that have been well characterized in humans
is miRNA [70–72].
Mammalian miRNA, recently reviewed here [73], regulate gene
expression as an integrated part of the RISC complex [74], which leads
to inhibition of translation and destabilization of the target transcript,
although the mechanistic details are still under debate and there are
rare exceptions where slicing occurs [75,76]. Each broadly conserved
mammalian miRNA targets hundreds of sites and N60% of all human
protein coding genes are conserved targets of miRNA [77]. Interest-
ingly, it was recently demonstrated that activation of T-cells causes a
switch in expression in favor of transcript isoforms with shorter 3′
UTRs [78]. For some transcripts investigated in detail, the shortening
of the 3′ UTR relieved negative miRNA regulation. Also, although the
canonical miRNA target sites resides within the 3′UTR, simultaneous
targeting of the 5′UTR increases the effect on the translational output
[79]. Many miRNAs are differentially expressed between tissues and
human cells transfected with tissue speciﬁc miRNA will change the
expression proﬁle to resemble the tissue from which the miRNA
originated [80,81]. During 2008, the ability of individual miRNA to
regulate hundreds of genes simultaneously was veriﬁed at the protein
level by quantitative mass spectrometry, although levels of most
proteins were only modestly changed [82,83]. This, however, does not
mean unimportance for development and disease. Several different
mutant mice carrying miRNA mutations display initial normal
viability to subsequently reveal severe phenotypic abnormalities
[84]. To date, N600 human miRNAs have been registered in the
miRBase (Release 12.0) database [85].
lRNA have attracted a lot of attention after the extent of
pervasive transcription was established for the mammalian genomes
[5–7,9,10,12,13] and the number of known functional lRNA is rapidly
increasing, as recently reported in two excellent reviews [86,87].
Brieﬂy, lRNA has been linked to gene regulation as an integral
component of chromatin [88,89] also affecting DNA methylation
[90]. Subsequently, antisense lRNA was shown to regulate the
methylation state of a tissue-dependent differentially regulated region
[91] and to change the epigenetic states of promoter regions, leading to
silencing of the affected genes [92,93]. lRNA is also involved in dosage
compensation. The best-known example of this is X-chromosome
inactivation, in which the transcriptional activity of large regions of
oneX-chromosome is silenced in human females. XIST, a 17-kbncRNA,
physically binds to large regions of the inactive X-chromosome,
causing heterochromatin formation [94]. A subset of autosomal genes
(∼150) are only expressed on one allele due to regulatory lRNA,which
controls the methylation status of a region denoted ICE (imprint
control region) [95].
Kapranov and colleagues mapped poly A+ lRNA in both the
cytosol and nucleus to sRNAs from the same cells [96]. In the cited
study, 2–10% of lRNA were identiﬁed as possible precursors for sRNAs
based on overlapping transcription and conservation patterns. These
sRNAs mappedmainly to 5′ and 3′ regions of known genes, 22–200 nt
long and was denoted PASRs (promoter-associated RNAs) and TASRs
(termini-associated RNAs). A large proportion of PASRs/TASRs
mapped into syntenic regions between human and mouse and
correlated with the expression of their corresponding genes. ∼45%
of all expressed genes harbored PASRs. Subsequently, PASRs were
investigated in more detail in an attempt to map transcripts b200 nt
in length in two human cell lines [97]. PASR expression patterns and
positions correlated to a high degree with CAGE tags [98] of lRNA.
sRNA and CAGE tags were ten times more likely to occur in exonic
than intronic regions and although PASRs could be the output of
independent transcription CAGE tag often bridged splice junctions
with the 5′ end being b20 nt away. This makes it unlikely for such a
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could be the result of a novel processing pathway of lRNA generating
small, capped ncRNAs. Synthetic sense and antisense PASRs were
demonstrated to reduce the expression of its corresponding mRNA,
which implies a possible regulatory function of these sRNAs. Another
novel short species of RNA was recently characterized by Taft and
colleagues [99] denoted transcription initiation RNAs (tiRNA). tiRNA
were predominantly 18 nucleotides in length, 190-fold strand-
speciﬁcally enriched at TSS and found at N20% of expressed genes.
Unlike PASRs the proportion of tiRNA did not increase when
sequencing RNA enriched for 5′ end CAP structures. Although genes
with tiRNA hosting promoters were on average more highly
expressed, the tiRNA expression did not correlate to the abundance
of its corresponding mRNA (Rb0.05).
Future perspectives — where do we go from here?
It is beyond reasonable doubt that the complexity of the
mammalian transcriptome far exceeds what was expected only a
decade ago. Different studies, e.g., deep sequencing [9,100] or
mapping of secondary structure elements in the genome [101]
suggest that many long and short non-coding RNAs still await
discovery, especially taxon speciﬁc species [102]. It may very well
be regulatory networks of RNA that convey the information required
to control development and thereby the phenotypes of the ∼100
trillion cells that make up the human body. The implications of its
recently demonstrated complexity remain to be determined, espe-
cially in different disease contexts. It is important to note that even
homogeneous population of cells will have different transcriptomes
[103–105]. The stochastic variability of gene expression can lead to
sub-phenotypes in genetically identical populations, which has been
demonstrated to increase ﬁtness in ﬂuctuating environments [106]
and to control lineage choices of mammalian progenitor cells [107].
Non-genetic variability was recently suggested by Brock and
colleagues [108] to be a driving force in cancer development. By
reason, the realization that the mammalian genomes can generate a
large diversity of cell phenotypes, such as liver and brain cells with the
same underlying genome, places the almost dogmatic somatic
mutation theory of cancer under scrutiny.
The continuous increase in read-length and throughput by the
next-generation of sequencers will aid in understanding the complex
gene regulatory networks, especially due to the distribution of the
mammalian transcriptome, where few transcripts are highly
expressed [109]. But although it is becoming possible to retrieve a
snapshot of the transcriptome, it is still not clear how tomake best use
of the massive amount of information retrieved by gene expression
assays. Recently a promising approach was undertaken where an
integrated analysis of genetic variation and gene expression assays
revealed relevant disease signatures [110,111]. The parallel use of
linkage- and gene expression data allowed for a direct connection
between genotype and phenotype, a prerequisite to distinguish the
variation that is causing a phenotype from the variation that is caused
by the phenotype. This rationale has also been successfully applied on
tumors from different forms of cancer [112,113]. Collectively, these
and other studies demonstrate that variation in the transcriptome, the
genome and the epigenome is best considered simultaneously in
order to unlock their true potential to contribute to the understanding
of disease pathogenesis and etiology.
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